Arkadios Wealth Advisors’s Sana Biotechnology SANA Stock Holding History

Arkadios Wealth Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.3K	Buy	+14,407	New	+$46.4K	﹤0.01%	1716

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Arkadios Wealth Advisors's SANA Position: Q2 2026 in Review

Arkadios Wealth Advisors opened a new position in Sana Biotechnology (SANA) in Q2 2026: 14,407 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #1716 among its holdings.

211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Arkadios Wealth Advisors held 14,407 shares of Sana Biotechnology worth $50.3K as of Q2 2026.
Sana Biotechnology was a new Arkadios Wealth Advisors position in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1716 holding.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.